In BC, it may act as a tumor suppressor [112] by recruiting immune effector cells [113] when it is expressed at higher levels in the tumor than in the adjacent healthy tissues [114], while IL-1β, TNFα, IL-6, and interferon (IFN)γ upregulate CCRL2 [115]. The gene discussed is CCRL2; the disease is neoplasm.